Fate Therapeutics
FATE
FATE
157 hedge funds and large institutions have $362M invested in Fate Therapeutics in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 169 → 157 (-12)
27% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 37
31% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 59
Holders
157
Holding in Top 10
1
Calls
$101K
Puts
$40K
Top Buyers
| 1 | +$12.8M | |
| 2 | +$6.36M | |
| 3 | +$4.54M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$3.37M |
| 5 |
Citigroup
New York
|
+$3.12M |
Top Sellers
| 1 | -$6.04M | |
| 2 | -$4.76M | |
| 3 | -$4.38M | |
| 4 |
D.E. Shaw & Co
New York
|
-$4.23M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.47M |